Innoviva has a total of 1936 patents globally, out of which 1012 have been granted. Of these 1936 patents, more than 30% patents are active. Europe (EPO) is where Innoviva has filed the maximum number of patents, followed by United States of America and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Innoviva.
Innoviva founded in 1996 as Advanced Medicine Inc. Innoviva Inc is a healthcare company with a portfolio of royalty-generating and strategic assets. Its operations span royalty investments, critical care, infectious disease, and other healthcare businesses, with products including Relvar/Breo/Ellipta, Anoro, and Trelegy. The company was renamed Theravance Inc in 2002 and rebranded as Innoviva Inc in 2016.
Do read about some of the most popular patents of Innoviva which have been covered by us in this article and also you can find Innoviva patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Innoviva patent portfolio.
How many patents does Innoviva have?
Innoviva has a total of 1936 patents globally. These patents belong to 272 unique patent families. Out of 1936 patents, 606 patents are active.
How Many Patents did Innoviva File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Innoviva Applications Filed | Innoviva Patents Granted |
| 2026 | 4 | 15 |
| 2025 | 10 | 27 |
| 2024 | 29 | 46 |
| 2023 | 21 | 32 |
| 2022 | 30 | 43 |
| 2021 | 6 | 28 |
| 2020 | 49 | 39 |
| 2019 | 51 | 61 |
| 2018 | 74 | 56 |
| 2017 | 155 | 59 |
How many Innoviva patents are Alive/Dead?
Worldwide Patents
How Many Patents did Innoviva File in Different Countries?
Countries in which Innoviva Filed Patents
| Country | Patents |
| Europe (EPO) | 160 |
| United States of America | 150 |
| Japan | 141 |
| India | 78 |
| Mexico | 76 |
| Australia | 69 |
| Austria | 63 |
| China | 59 |
| Italy | 56 |
| Hong Kong (S.A.R.) | 50 |
| Korea (South) | 47 |
| Canada | 45 |
| Malaysia | 43 |
| Singapore | 41 |
| Argentina | 40 |
| Taiwan | 39 |
| Poland | 38 |
| Brazil | 38 |
| Philippines | 38 |
| Israel | 36 |
| Germany | 35 |
| Cyprus | 30 |
| Spain | 28 |
| New Zealand | 28 |
| South Africa | 27 |
| Norway | 22 |
| Colombia | 22 |
| Viet Nam | 18 |
| Denmark | 17 |
| Hungary | 16 |
| Russia | 16 |
| Thailand | 15 |
| Indonesia | 15 |
| Morocco | 14 |
| Eurasia | 14 |
| Slovenia | 13 |
| Portugal | 13 |
| Malta | 12 |
| Croatia | 11 |
| Turkey | 11 |
| Slovakia | 11 |
| Chile | 10 |
| Peru | 9 |
| Estonia | 8 |
| Serbia | 8 |
| Albania | 7 |
| Lithuania | 7 |
| Macao | 6 |
| Iceland | 6 |
| San Marino | 5 |
| Montenegro | 4 |
| Algeria | 4 |
| Saudi Arabia | 3 |
| Gulf Cooperation Council | 3 |
| Pakistan | 3 |
| Georgia | 2 |
| Luxembourg | 2 |
| Egypt | 1 |
| Netherlands | 1 |
| Africa | 1 |
| France | 1 |
| Finland | 1 |
| Yugoslavia/Serbia and Montenegro | 1 |
Where are Research Centres of Innoviva Patents Located?
Top Patents Contributing subsidiaries of Innoviva
10 Best Innoviva Patents
WO2007120528A2 is the most popular patent in the Innoviva portfolio. It has received 249 citations so far from companies like Pharmaxis Ltd, Acucela Inc and Eli Lilly & Co.
Below is the list of 10 most cited patents of Innoviva:
| Publication Number | Citation Count |
| WO2007120528A2 | 249 |
| WO2006023457A1 | 101 |
| WO2009029257A1 | 74 |
| WO2012021712A1 | 65 |
| WO2010123766A1 | 64 |
| WO2006023454A1 | 64 |
| WO2010129055A1 | 61 |
| US7439253B2 | 59 |
| US8658641B2 | 52 |
| WO2012082853A1 | 47 |
What are Innoviva key innovation segments?
What Technologies are Covered by Innoviva?
The chart below distributes patents filed by Innoviva